Mucosal immunization in perspective.

Area of Science:

• Immunology
• Vaccinology
• Public Health

Background:

• Influenza viruses pose a significant global health risk, causing widespread illness and death.
• Current influenza vaccines are mostly administered parenterally, despite infections occurring at mucosal surfaces.
• Novel vaccine delivery methods targeting mucosal surfaces are being explored.

Purpose of the Study:

• To evaluate the potential of intranasal influenza vaccines as a viable alternative to parenteral vaccination.
• To compare the immunogenicity and efficacy of intranasal versus intramuscular influenza vaccination.
• To assess the advantages of intranasal administration for mass immunization.

Main Methods:

• Clinical studies comparing intranasal live attenuated influenza vaccine (LAIV) with intramuscular vaccination.
• Assessment of immunogenicity and efficacy in the upper and lower respiratory tracts.

Main Results:

• Intranasal LAIV demonstrated equivalent or superior immunogenicity and efficacy compared to intramuscular vaccination.
• Intranasal administration proved to be an easy and painless method of delivery.
• The approach facilitates mass immunization campaigns due to its non-sterile and simple application.

Conclusions:

• Intranasal influenza vaccination is a viable and potentially superior approach to parenteral vaccination.
• The ease of administration and efficacy make intranasal vaccines highly suitable for widespread public health initiatives.
• Further development and implementation of intranasal influenza vaccines could significantly improve disease control.